GENEVA, July 1 -- CALIWAY BIOPHARMACEUTICALS CO., LTD. filed a patent application (CN2025/132934) for “PHARMACEUTICAL FORMULATIONS OF CURCUMIN AND/OR RESVERATROL COMPOUNDS”. With publication no. WO/2026/098542, here are the other details related to the patent application:
Kind: Corrected version of pamphlet [A9]
IPC: A61K 31/12
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....